Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience (407 views)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2017 Nov 06; 59(1): 90-101.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Multicenter Study, Observational Study,
Impact factor: 3.179, 5-year impact factor: 3.057
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033432983&doi=10.1007%2fs12020-017-1455-6&partnerID=40&md5=d29ed58e9e27bb8fc9d07f6bdb32f17e
Keywords: Bone Metastases, Denosumab-Radioiodine, Thyroid Carcinoma, Zoledronate, Radioactive Iodine, Zoledronic Acid, Adolescent, Adult, Aged, Article, Bone Biopsy, Cancer Localization, Cancer Mortality, Cancer Surgery, Cause Of Death, Child, Cohort Analysis, Computer Assisted Tomography, Controlled Study, Differentiated Thyroid Cancer, Disease Association, External Beam Radiotherapy, Female, Hazard Ratio, Human, Hypercalcemia, Informed Consent, Major Clinical Study, Multicenter Study, Nuclear Magnetic Resonance Imaging, Observational Study, Pathologic Fracture, Positron Emission Tomography, Practice Guideline, Priority Journal, Retrospective Study, Spinal Cord Compression, Bone Tumor, Clinical Trial, Middle Aged, Prognosis, Secondary, Thyroid Tumor, Treatment Outcome, Very Elderly, Young Adult, 80 And Over, Bone Neoplasms, Retrospective Studies, Thyroid Neoplasms, Diagnosis, Epidemiology, Bone Neoplasms Diagnosis Epidemiology Secondary Therapy , Thyroid Neoplasms Diagnosis Epidemiology Pathology Therapy,
Affiliations:
*** IBB - CNR ***
Endocrine Unit, ASST Carlo Poma, Mantua, Italy., Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy., Nuclear Medicine, University of Brescia, Brescia, Italy., Oncological Endocrinology, University of Turin, Torino, Italy., Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy., Nuclear Medicine, University of Naples Federico II, Napoli, Italy., Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy., Internal Medicine, University Sapienza of Rome, Roma, Italy., Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Nuclear Medicine, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Reggio Emilia, Italy., Department of Medicine and Surgery, University of Salerno, Fisciano, Italy., Institute of Biostructure and Bioimaging of the National Research Council of Italy-CNR, Naples, Italy., Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy., San Raffaele Vita-Salute University, Milan, Italy., Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy., San Raffaele Vita-Salute University, Milan, Italy. giustina.andrea@hsr.it.,
Nuclear Medicine, “S. Maria della Misericordia” Hospital, Perugia, Italy
Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy.
Nuclear Medicine, University of Brescia, Brescia, Italy.
Oncological Endocrinology, University of Turin, Torino, Italy.
Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy.
Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy.
Internal Medicine, University Sapienza of Rome, Roma, Italy.
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of
References:
Muresan, M.M., Olivier, P., Leclère, J., Sirveaux, F., Brunaud, L., Klein, M., Zarnegar, R., Weryha, G., Bone metastases from differentiated thyroid carcinoma (2008) Endocr. Relat. Cancer, 15, pp. 37-49. , COI: 1:CAS:528:DC%2BD1cXkslKntbk%3D, PID: 1831027
Durante, C., Haddy, N., Baudin, E., Leboulleux, S., Hartl, D., Travagli, J.P., Caillou, B., Schlumberger, M., Long term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy (2006) J. Clin. Endocrinol. Metab., 91, pp. 2892-2899. , COI: 1:CAS:528:DC%2BD28XosFGhs70%3D, PID: 16684830
Lin, J.D., Huang, M.J., Juang, J.H., Chao, T.C., Huang, B.Y., Chen, K.W., Chen, J.Y., Ho, Y.S., Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases (1999) Thyroid, 9, pp. 1227-1235. , COI: 1:STN:280:DC%2BD3c7htVGrsQ%3D%3D, PID: 10646663
Marcocci, C., Pacini, F., Elisei, R., Schipani, E., Ceccarelli, C., Miccoli, P., Arganini, M., Pinchera, A., Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma (1989) Surgery, 106, pp. 960-966. , COI: 1:STN:280:DyaK3c%2FmvFymsw%3D%3D, PID: 2588123
Pittas, A.G., Adler, M., Fazzari, M., Tickoo, S., Rosai, J., Larson, S.M., Robbins, R.J., Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients (2000) Thyroid, 10, pp. 261-268. , COI: 1:STN:280:DC%2BD3c3jvFCisA%3D%3D, PID: 10779141
Farooki, A., Leung, V., Tala, H., Tuttle, R.M., Skeletal-related events due to bone metastases from differentiated thyroid cancer (2012) J. Clin. Endocrinol. Metab., 97, pp. 2433-2439. , COI: 1:CAS:528:DC%2BC38XhtFGgs7jO, PID: 22564664
Tucci, M., Mosca, A., Lamanna, G., Porpiglia, F., Terzolo, M., Vana, F., Cracco, C., Berruti, A., Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease (2009) Prostate Cancer Prostatic Dis., 12, pp. 94-99. , COI: 1:CAS:528:DC%2BD1MXhs1aitLY%3D, PID: 18332901
Cooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Mazzaferri, E.L., Tuttle, R.M., Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer (2009) Thyroid, 19, pp. 1167-1214. , PID: 19860577
Haugen, B.R., Alexander, E.K., Bible, K.C., Doherty, G.M., Mandel, S.J., Nikiforov, Y.E., Pacini, F., Wartofsky, L., American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer (2016) Thyroid, 26, pp. 1-133. , PID: 26462967
Orita, Y., Sugitani, I., Toda, K., Manabe, J., Fujimoto, Y., Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma (2011) Thyroid, 21, pp. 31-35. , COI: 1:CAS:528:DC%2BC3MXktVKjtw%3D%3D, PID: 21058881
Vitale, G., Fonderico, F., Martignetti, A., Caraglia, M., Ciccarelli, A., Nuzzo, V., Abbruzzese, A., Lupoli, G., Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer (2001) Br. J. Cancer, 84, pp. 1586-1590. , COI: 1:CAS:528:DC%2BD3MXlt1Oht7o%3D, PID: 11401309
Lipton, A., Fizazi, K., Stopeck, A.T., Henry, D.H., Smith, M.R., Shore, N., Martin, M., Braun, A., Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics (2016) Eur. J. Cancer, 53, pp. 75-83. , COI: 1:CAS:528:DC%2BC2MXhvFems7bO, PID: 26693901
Liu, J., Huang, W., Zhou, R., Jia, S., Tang, W., Luo, Y., Zhang, J., Bisphosphonates in the treatment of patients with metastatic breast, lung, and prostate cancer: a meta-analysis (2015) Medicine, 94. , e2014
Santini, D., Procopio, G., Porta, C., Ibrahim, T., Barni, S., Mazzara, C., Fontana, A., Bracarda, S., Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey (2013) PLoS ONE, 30
Beierwaltes, W.H., Nishiyama, R.H., Thompson, N.W., Copp, J.E., Kubo, A., Survival time and “cure” in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy (1982) J. Nucl. Med., 23, pp. 561-568. , COI: 1:STN:280:DyaL383hs1ShtQ%3D%3D, PID: 7086528
Schlumberger, M., Challeton, C., De Vathaire, F., Travagli, J.P., Gardet, P., Lumbroso, J.D., Francese, C., Parmentier, C., Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma (1996) J. Nucl. Med., 37, pp. 598-605. , COI: 1:CAS:528:DyaK28XislKlurY%3D, PID: 8691248
Mizukami, Y., Mishigishi, T., Nonomura, A., Hashimoto, T., Terahata, S., Noguchi, M., Hisada, K., Matsubara, F., Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study (1990) Hum. Pathol., 21, pp. 283-290. , COI: 1:STN:280:DyaK3c7osFKmtg%3D%3D, PID: 2312106
Ruegemer, J.J., Hay, I.D., Bergstralh, E.J., Ryan, J.J., Offord, K.P., Gorman, C.A., Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables (1988) J. Clin. Endocrinol. Metab., 67, pp. 501-508. , COI: 1:STN:280:DyaL1czhsFantA%3D%3D, PID: 3410936
Tickoo, S.K., Pittas, A.G., Adler, M., Fazzari, M., Larson, S.M., Robbins, R.J., Rosai, J., Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates (2000) Arch. Pathol. Lab. Med., 124, pp. 1440-1447. , COI: 1:STN:280:DC%2BD3M%2FhvVWmsw%3D%3D, PID: 11035572
Nikiforov, Y.E., Seethala, R.R., Tallini, G., Baloch, Z.W., Basolo, F., Thompson, L.D., Barletta, J.A., Ghossein, R.A., Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors (2016) JAMA Oncol., 2, pp. 1023-1029. , PID: 27078145
Hindié, E., Zanotti-Fregonara, P., Keller, I., Duron, F., Devaux, J.Y., Calzada-Nocaudie, M., Sarfati, E., Toubert, M.E., Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome (2007) Endocr. Rel. Cancer, 14, pp. 799-807
Verburg, F.A., Aktolun, C., Chiti, A., Frangos, S., Giovanella, L., Hoffmann, M., Iakovou, I., Luster, M., Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer (2016) Eur. J. Nucl. Med. Mol. Imaging, 43, pp. 1001-1005. , PID: 26883666
Harel, R., Angelov, L., Spine metastases: current treatments and future directions (2010) Eur. J. Cancer, 46, pp. 2696-2707. , PID: 20627705
Bonadonna, S., Mazziotti, G., Nuzzo, M., Bianchi, A., Fusco, A., De Marinis, L., Giustina, A., Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women (2005) J. Bone Miner. Res., 20, pp. 1837-1844. , PID: 16160741
Mancini, T., Mazziotti, G., Doga, M., Carpinteri, R., Simetovic, N., Vescovi, P.P., Giustina, A., Vertebral fractures in males with type 2 diabetes treated with rosiglitazone (2009) Bone, 45, pp. 784-788. , COI: 1:CAS:528:DC%2BD1MXhtVehurzK, PID: 19527806
Mazziotti, G., Porcelli, T., Mormando, M., De Menis, E., Bianchi, A., Mejia, C., Mancini, T., Giustina, A., Vertebral fractures in males with prolactinoma (2011) Endocrine, 39, pp. 288-293. , COI: 1:CAS:528:DC%2BC3MXksVCrt7k%3D, PID: 21479837
Mazziotti, G., Baracca, M., Doga, M., Porcelli, T., Vescovi, P.P., Giustina, A., Prevalence of thoracic vertebral fractures in hospitalized elderly patients with heart failure (2012) Eur. J. Endocrinol., 167, pp. 865-872. , COI: 1:CAS:528:DC%2BC38Xhsl2iu7nK, PID: 22968484
Torti, C., Mazziotti, G., Soldini, P.A., Focà, E., Maroldi, R., Gotti, D., Carosi, G., Giustina, A., High prevalence of radiological vertebral fractures in HIV-infected males (2012) Endocrine, 41, pp. 512-517. , COI: 1:CAS:528:DC%2BC3MXhs1OjsLzJ, PID: 22198528
Mazziotti, G., Bianchi, A., Porcelli, T., Mormando, M., Maffezzoni, F., Cristiano, A., Giampietro, A., Giustina, A., Vertebral fractures in patients with acromegaly: a 3-year prospective study (2013) J. Clin. Endocrinol. Metab., 98, pp. 3402-3410. , COI: 1:CAS:528:DC%2BC3sXht12gsLnN, PID: 23771918
Mazziotti, G., Dordoni, C., Doga, M., Galderisi, F., Venturini, M., Calzavara-Pinton, P., Maroldi, R., Colombi, M., High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome (2016) Bone, 84, pp. 88-92. , COI: 1:STN:280:DC%2BC28rltFWjsA%3D%3D, PID: 26708925
Pedersini, R., Monteverdi, S., Mazziotti, G., Amoroso, V., Roca, E., Maffezzoni, F., Vassalli, L., Giustina, A., Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: a cross-sectional study (2017) Bone, 97, pp. 147-152. , COI: 1:CAS:528:DC%2BC2sXhsFGqt74%3D, PID: 28104509
Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Biondi, B., Iorio, S., Carella, C., Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma (2005) J. Bone Miner. Res., 20, pp. 480-486. , COI: 1:CAS:528:DC%2BD2MXis1Knu7Y%3D, PID: 15746993
Mazziotti, G., Mormando, M., Cristiano, A., Bianchi, A., Porcelli, T., Giampietro, A., Maffezzoni, F., Giustina, A., Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism (2014) Eur. J. Endocrinol., 170, pp. 893-899. , COI: 1:CAS:528:DC%2BC2cXhtVamtLjN, PID: 24836549
Bernier, M.O., Leenhardt, L., Hoang, C., Aurengo, A., Mary, J.Y., Menegaux, F., Enkaoua, E., Hejblum, G., Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas (2001) J. Clin. Endocrinol. Metab., 86, pp. 1568-1573. , COI: 1:CAS:528:DC%2BD3MXivVClur0%3D, PID: 11297585
Zettinig, G., Fueger, B.J., Passler, C., Kaserer, K., Pirich, C., Dudczak, R., Niederle, B., Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma—surgery or conventional therapy? (2002) Clin. Endocrinol., 56, pp. 377-382
Ramadan, S., Ugas, M.A., Berwick, R.J., Notay, M., Cho, H., Jerjes, W., Giannoudis, P.V., Spinal metastasis in thyroid cancer (2012) Head Neck Oncol., 4, p. 39. , COI: 1:CAS:528:DC%2BC38Xjt1ansbk%3D, PID: 22730910
Weiss, R.J., Ekström, W., Hansen, B.H., Keller, J., Laitinen, M., Trovik, C., Zaikova, O., Wedin, R., Pathological subtrochanteric fractures in 194 patients: a comparison of outcome after surgical treatment of pathological and non-pathological fractures (2013) J. Surg. Oncol., 107, pp. 498-504. , PID: 23070922
Smith, T., Pelpola, K., Ball, M., Ong, A., Myint, P.K., Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis (2014) Age Ageing, 43, pp. 464-471. , PID: 24895018
Kilci, O., Un, C., Sacan, O., Gamli, M., Baskan, S., Baydar, M., Ozkurt, B., Postoperative mortality after hip fracture surgery: a 3 years follow -up (2016) PLoS ONE, 11. , PID: 27788137, 27
Choi, Y.M., Kim, W.G., Kwon, H., Jeon, M.J., Lee, J.J., Ryu, J.S., Hong, E.G., Kim, W.B., Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma (2016) Eur. J. Endocrinol., 175, pp. 165-172. , COI: 1:CAS:528:DC%2BC2sXhtFyms7fI, PID: 27272238
Qiu, Z.L., Song, H.J., Xu, Y.H., Luo, Q.Y., Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer (2011) J. Clin. Endocrinol. Metab., 96, pp. 3078-3086. , COI: 1:CAS:528:DC%2BC3MXhtlyitbnP, PID: 21795449
Roodman, G.D., Mechanisms of bone metastasis (2004) N. Engl. J. Med., 350, pp. 1655-1664. , COI: 1:CAS:528:DC%2BD2cXjt1WksLY%3D, PID: 15084698
Fizazi, K., Lipton, A., Mariette, X., Body, J.J., Rahim, Y., Gralow, J.R., Gao, G., Jun, S., Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates (2009) J. Clin. Oncol., 27, pp. 1564-1571. , COI: 1:CAS:528:DC%2BD1MXltVOhtr0%3D, PID: 19237632
Mazziotti, G., Canalis, E., Giustina, A., Drug-induced osteoporosis: mechanisms and clinical implications (2010) Am. J. Med., 123, pp. 877-884. , COI: 1:CAS:528:DC%2BC3cXht1eqtLfJ, PID: 20920685
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2017 Nov 06; 59(1): 90-101.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Multicenter Study, Observational Study,
Impact factor: 3.179, 5-year impact factor: 3.057
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033432983&doi=10.1007%2fs12020-017-1455-6&partnerID=40&md5=d29ed58e9e27bb8fc9d07f6bdb32f17e
Keywords: Bone Metastases, Denosumab-Radioiodine, Thyroid Carcinoma, Zoledronate, Radioactive Iodine, Zoledronic Acid, Adolescent, Adult, Aged, Article, Bone Biopsy, Cancer Localization, Cancer Mortality, Cancer Surgery, Cause Of Death, Child, Cohort Analysis, Computer Assisted Tomography, Controlled Study, Differentiated Thyroid Cancer, Disease Association, External Beam Radiotherapy, Female, Hazard Ratio, Human, Hypercalcemia, Informed Consent, Major Clinical Study, Multicenter Study, Nuclear Magnetic Resonance Imaging, Observational Study, Pathologic Fracture, Positron Emission Tomography, Practice Guideline, Priority Journal, Retrospective Study, Spinal Cord Compression, Bone Tumor, Clinical Trial, Middle Aged, Prognosis, Secondary, Thyroid Tumor, Treatment Outcome, Very Elderly, Young Adult, 80 And Over, Bone Neoplasms, Retrospective Studies, Thyroid Neoplasms, Diagnosis, Epidemiology, Bone Neoplasms Diagnosis Epidemiology Secondary Therapy , Thyroid Neoplasms Diagnosis Epidemiology Pathology Therapy,
Affiliations:
*** IBB - CNR ***
Endocrine Unit, ASST Carlo Poma, Mantua, Italy., Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy., Nuclear Medicine, University of Brescia, Brescia, Italy., Oncological Endocrinology, University of Turin, Torino, Italy., Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy., Nuclear Medicine, University of Naples Federico II, Napoli, Italy., Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy., Internal Medicine, University Sapienza of Rome, Roma, Italy., Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Nuclear Medicine, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Reggio Emilia, Italy., Department of Medicine and Surgery, University of Salerno, Fisciano, Italy., Institute of Biostructure and Bioimaging of the National Research Council of Italy-CNR, Naples, Italy., Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy., San Raffaele Vita-Salute University, Milan, Italy., Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy., San Raffaele Vita-Salute University, Milan, Italy. giustina.andrea@hsr.it.,
Nuclear Medicine, “S. Maria della Misericordia” Hospital, Perugia, Italy
Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy.
Nuclear Medicine, University of Brescia, Brescia, Italy.
Oncological Endocrinology, University of Turin, Torino, Italy.
Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy.
Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy.
Internal Medicine, University Sapienza of Rome, Roma, Italy.
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of
References:
Muresan, M.M., Olivier, P., Leclère, J., Sirveaux, F., Brunaud, L., Klein, M., Zarnegar, R., Weryha, G., Bone metastases from differentiated thyroid carcinoma (2008) Endocr. Relat. Cancer, 15, pp. 37-49. , COI: 1:CAS:528:DC%2BD1cXkslKntbk%3D, PID: 1831027
Durante, C., Haddy, N., Baudin, E., Leboulleux, S., Hartl, D., Travagli, J.P., Caillou, B., Schlumberger, M., Long term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy (2006) J. Clin. Endocrinol. Metab., 91, pp. 2892-2899. , COI: 1:CAS:528:DC%2BD28XosFGhs70%3D, PID: 16684830
Lin, J.D., Huang, M.J., Juang, J.H., Chao, T.C., Huang, B.Y., Chen, K.W., Chen, J.Y., Ho, Y.S., Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases (1999) Thyroid, 9, pp. 1227-1235. , COI: 1:STN:280:DC%2BD3c7htVGrsQ%3D%3D, PID: 10646663
Marcocci, C., Pacini, F., Elisei, R., Schipani, E., Ceccarelli, C., Miccoli, P., Arganini, M., Pinchera, A., Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma (1989) Surgery, 106, pp. 960-966. , COI: 1:STN:280:DyaK3c%2FmvFymsw%3D%3D, PID: 2588123
Pittas, A.G., Adler, M., Fazzari, M., Tickoo, S., Rosai, J., Larson, S.M., Robbins, R.J., Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients (2000) Thyroid, 10, pp. 261-268. , COI: 1:STN:280:DC%2BD3c3jvFCisA%3D%3D, PID: 10779141
Farooki, A., Leung, V., Tala, H., Tuttle, R.M., Skeletal-related events due to bone metastases from differentiated thyroid cancer (2012) J. Clin. Endocrinol. Metab., 97, pp. 2433-2439. , COI: 1:CAS:528:DC%2BC38XhtFGgs7jO, PID: 22564664
Tucci, M., Mosca, A., Lamanna, G., Porpiglia, F., Terzolo, M., Vana, F., Cracco, C., Berruti, A., Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease (2009) Prostate Cancer Prostatic Dis., 12, pp. 94-99. , COI: 1:CAS:528:DC%2BD1MXhs1aitLY%3D, PID: 18332901
Cooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Mazzaferri, E.L., Tuttle, R.M., Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer (2009) Thyroid, 19, pp. 1167-1214. , PID: 19860577
Haugen, B.R., Alexander, E.K., Bible, K.C., Doherty, G.M., Mandel, S.J., Nikiforov, Y.E., Pacini, F., Wartofsky, L., American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer (2016) Thyroid, 26, pp. 1-133. , PID: 26462967
Orita, Y., Sugitani, I., Toda, K., Manabe, J., Fujimoto, Y., Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma (2011) Thyroid, 21, pp. 31-35. , COI: 1:CAS:528:DC%2BC3MXktVKjtw%3D%3D, PID: 21058881
Vitale, G., Fonderico, F., Martignetti, A., Caraglia, M., Ciccarelli, A., Nuzzo, V., Abbruzzese, A., Lupoli, G., Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer (2001) Br. J. Cancer, 84, pp. 1586-1590. , COI: 1:CAS:528:DC%2BD3MXlt1Oht7o%3D, PID: 11401309
Lipton, A., Fizazi, K., Stopeck, A.T., Henry, D.H., Smith, M.R., Shore, N., Martin, M., Braun, A., Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics (2016) Eur. J. Cancer, 53, pp. 75-83. , COI: 1:CAS:528:DC%2BC2MXhvFems7bO, PID: 26693901
Liu, J., Huang, W., Zhou, R., Jia, S., Tang, W., Luo, Y., Zhang, J., Bisphosphonates in the treatment of patients with metastatic breast, lung, and prostate cancer: a meta-analysis (2015) Medicine, 94. , e2014
Santini, D., Procopio, G., Porta, C., Ibrahim, T., Barni, S., Mazzara, C., Fontana, A., Bracarda, S., Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey (2013) PLoS ONE, 30
Beierwaltes, W.H., Nishiyama, R.H., Thompson, N.W., Copp, J.E., Kubo, A., Survival time and “cure” in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy (1982) J. Nucl. Med., 23, pp. 561-568. , COI: 1:STN:280:DyaL383hs1ShtQ%3D%3D, PID: 7086528
Schlumberger, M., Challeton, C., De Vathaire, F., Travagli, J.P., Gardet, P., Lumbroso, J.D., Francese, C., Parmentier, C., Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma (1996) J. Nucl. Med., 37, pp. 598-605. , COI: 1:CAS:528:DyaK28XislKlurY%3D, PID: 8691248
Mizukami, Y., Mishigishi, T., Nonomura, A., Hashimoto, T., Terahata, S., Noguchi, M., Hisada, K., Matsubara, F., Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study (1990) Hum. Pathol., 21, pp. 283-290. , COI: 1:STN:280:DyaK3c7osFKmtg%3D%3D, PID: 2312106
Ruegemer, J.J., Hay, I.D., Bergstralh, E.J., Ryan, J.J., Offord, K.P., Gorman, C.A., Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables (1988) J. Clin. Endocrinol. Metab., 67, pp. 501-508. , COI: 1:STN:280:DyaL1czhsFantA%3D%3D, PID: 3410936
Tickoo, S.K., Pittas, A.G., Adler, M., Fazzari, M., Larson, S.M., Robbins, R.J., Rosai, J., Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates (2000) Arch. Pathol. Lab. Med., 124, pp. 1440-1447. , COI: 1:STN:280:DC%2BD3M%2FhvVWmsw%3D%3D, PID: 11035572
Nikiforov, Y.E., Seethala, R.R., Tallini, G., Baloch, Z.W., Basolo, F., Thompson, L.D., Barletta, J.A., Ghossein, R.A., Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors (2016) JAMA Oncol., 2, pp. 1023-1029. , PID: 27078145
Hindié, E., Zanotti-Fregonara, P., Keller, I., Duron, F., Devaux, J.Y., Calzada-Nocaudie, M., Sarfati, E., Toubert, M.E., Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome (2007) Endocr. Rel. Cancer, 14, pp. 799-807
Verburg, F.A., Aktolun, C., Chiti, A., Frangos, S., Giovanella, L., Hoffmann, M., Iakovou, I., Luster, M., Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer (2016) Eur. J. Nucl. Med. Mol. Imaging, 43, pp. 1001-1005. , PID: 26883666
Harel, R., Angelov, L., Spine metastases: current treatments and future directions (2010) Eur. J. Cancer, 46, pp. 2696-2707. , PID: 20627705
Bonadonna, S., Mazziotti, G., Nuzzo, M., Bianchi, A., Fusco, A., De Marinis, L., Giustina, A., Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women (2005) J. Bone Miner. Res., 20, pp. 1837-1844. , PID: 16160741
Mancini, T., Mazziotti, G., Doga, M., Carpinteri, R., Simetovic, N., Vescovi, P.P., Giustina, A., Vertebral fractures in males with type 2 diabetes treated with rosiglitazone (2009) Bone, 45, pp. 784-788. , COI: 1:CAS:528:DC%2BD1MXhtVehurzK, PID: 19527806
Mazziotti, G., Porcelli, T., Mormando, M., De Menis, E., Bianchi, A., Mejia, C., Mancini, T., Giustina, A., Vertebral fractures in males with prolactinoma (2011) Endocrine, 39, pp. 288-293. , COI: 1:CAS:528:DC%2BC3MXksVCrt7k%3D, PID: 21479837
Mazziotti, G., Baracca, M., Doga, M., Porcelli, T., Vescovi, P.P., Giustina, A., Prevalence of thoracic vertebral fractures in hospitalized elderly patients with heart failure (2012) Eur. J. Endocrinol., 167, pp. 865-872. , COI: 1:CAS:528:DC%2BC38Xhsl2iu7nK, PID: 22968484
Torti, C., Mazziotti, G., Soldini, P.A., Focà, E., Maroldi, R., Gotti, D., Carosi, G., Giustina, A., High prevalence of radiological vertebral fractures in HIV-infected males (2012) Endocrine, 41, pp. 512-517. , COI: 1:CAS:528:DC%2BC3MXhs1OjsLzJ, PID: 22198528
Mazziotti, G., Bianchi, A., Porcelli, T., Mormando, M., Maffezzoni, F., Cristiano, A., Giampietro, A., Giustina, A., Vertebral fractures in patients with acromegaly: a 3-year prospective study (2013) J. Clin. Endocrinol. Metab., 98, pp. 3402-3410. , COI: 1:CAS:528:DC%2BC3sXht12gsLnN, PID: 23771918
Mazziotti, G., Dordoni, C., Doga, M., Galderisi, F., Venturini, M., Calzavara-Pinton, P., Maroldi, R., Colombi, M., High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome (2016) Bone, 84, pp. 88-92. , COI: 1:STN:280:DC%2BC28rltFWjsA%3D%3D, PID: 26708925
Pedersini, R., Monteverdi, S., Mazziotti, G., Amoroso, V., Roca, E., Maffezzoni, F., Vassalli, L., Giustina, A., Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: a cross-sectional study (2017) Bone, 97, pp. 147-152. , COI: 1:CAS:528:DC%2BC2sXhsFGqt74%3D, PID: 28104509
Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Biondi, B., Iorio, S., Carella, C., Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma (2005) J. Bone Miner. Res., 20, pp. 480-486. , COI: 1:CAS:528:DC%2BD2MXis1Knu7Y%3D, PID: 15746993
Mazziotti, G., Mormando, M., Cristiano, A., Bianchi, A., Porcelli, T., Giampietro, A., Maffezzoni, F., Giustina, A., Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism (2014) Eur. J. Endocrinol., 170, pp. 893-899. , COI: 1:CAS:528:DC%2BC2cXhtVamtLjN, PID: 24836549
Bernier, M.O., Leenhardt, L., Hoang, C., Aurengo, A., Mary, J.Y., Menegaux, F., Enkaoua, E., Hejblum, G., Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas (2001) J. Clin. Endocrinol. Metab., 86, pp. 1568-1573. , COI: 1:CAS:528:DC%2BD3MXivVClur0%3D, PID: 11297585
Zettinig, G., Fueger, B.J., Passler, C., Kaserer, K., Pirich, C., Dudczak, R., Niederle, B., Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma—surgery or conventional therapy? (2002) Clin. Endocrinol., 56, pp. 377-382
Ramadan, S., Ugas, M.A., Berwick, R.J., Notay, M., Cho, H., Jerjes, W., Giannoudis, P.V., Spinal metastasis in thyroid cancer (2012) Head Neck Oncol., 4, p. 39. , COI: 1:CAS:528:DC%2BC38Xjt1ansbk%3D, PID: 22730910
Weiss, R.J., Ekström, W., Hansen, B.H., Keller, J., Laitinen, M., Trovik, C., Zaikova, O., Wedin, R., Pathological subtrochanteric fractures in 194 patients: a comparison of outcome after surgical treatment of pathological and non-pathological fractures (2013) J. Surg. Oncol., 107, pp. 498-504. , PID: 23070922
Smith, T., Pelpola, K., Ball, M., Ong, A., Myint, P.K., Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis (2014) Age Ageing, 43, pp. 464-471. , PID: 24895018
Kilci, O., Un, C., Sacan, O., Gamli, M., Baskan, S., Baydar, M., Ozkurt, B., Postoperative mortality after hip fracture surgery: a 3 years follow -up (2016) PLoS ONE, 11. , PID: 27788137, 27
Choi, Y.M., Kim, W.G., Kwon, H., Jeon, M.J., Lee, J.J., Ryu, J.S., Hong, E.G., Kim, W.B., Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma (2016) Eur. J. Endocrinol., 175, pp. 165-172. , COI: 1:CAS:528:DC%2BC2sXhtFyms7fI, PID: 27272238
Qiu, Z.L., Song, H.J., Xu, Y.H., Luo, Q.Y., Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer (2011) J. Clin. Endocrinol. Metab., 96, pp. 3078-3086. , COI: 1:CAS:528:DC%2BC3MXhtlyitbnP, PID: 21795449
Roodman, G.D., Mechanisms of bone metastasis (2004) N. Engl. J. Med., 350, pp. 1655-1664. , COI: 1:CAS:528:DC%2BD2cXjt1WksLY%3D, PID: 15084698
Fizazi, K., Lipton, A., Mariette, X., Body, J.J., Rahim, Y., Gralow, J.R., Gao, G., Jun, S., Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates (2009) J. Clin. Oncol., 27, pp. 1564-1571. , COI: 1:CAS:528:DC%2BD1MXltVOhtr0%3D, PID: 19237632
Mazziotti, G., Canalis, E., Giustina, A., Drug-induced osteoporosis: mechanisms and clinical implications (2010) Am. J. Med., 123, pp. 877-884. , COI: 1:CAS:528:DC%2BC3cXht1eqtLfJ, PID: 20920685
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience
Purpose and Patients: The M.O.S.CA.TI. (Metastases of the Skeleton from CArcinoma of the ThyroId) is a multicenter, retrospective study investigating the real-life outcome and management of bone metastases (BM) in 143 patients (63 M, 80 F; median age 64 years, range 11–87) with differentiated thyroid carcinoma (DTC). Results: Radio-active iodine (RAI) treatment was performed in 131 patients (91.6%), surgical approach and/or external radiotherapy in 68 patients (47.6%), and anti-resorptive bone-active drugs in 32 patients (22.4%; in 31 zoledronate and in one denosumab). At the start of treatment, 24 patients (75.0%) receiving anti-resorptive bone-active drugs had at least one clinical skeletal-related event (SRE) (p < 0.001). One or more clinical SREs (pathological fractures and/or malignant hypercalcemia and/or spinal cord compression) developed in 53 patients (37.1%). Development of SREs was significantly associated with metachronous BM (hazard ratio (HR) 2.04; p = 0.04), localization of BM to cervical spine (HR 3.89; p = 0.01), and lack of avid RAI uptake (HR 2.66; p = 0.02). Thirty-nine patients (27.3%) died in correlation with development of SREs (HR 6.97; p = 0.006) and localization of BM to the hip (HR 3.86; p = 0.02). Moreover, overall mortality was significantly decreased by RAI therapy (HR 0.10; p = 0.02), whereas no significant effects were induced by bone-active drugs (p = 0.36), external radiotherapy (p = 0.54), and surgery (p = 0.43) of BM. Conclusions: SREs are very frequent in BM from DTC and they impact patient survival. In the real life, the use of bone-active drugs is currently limited to zoledronate in patients with pre-existing SREs. In this clinical setting, RAI therapy, but not zoledronate, decreased mortality. © 2017, Springer Science+Business Media, LLC.
Purpose and Patients: The M.O.S.CA.TI. (Metastases of the Skeleton from CArcinoma of the ThyroId) is a multicenter, retrospective study investigating the real-life outcome and management of bone metastases (BM) in 143 patients (63 M, 80 F; median age 64 years, range 11–87) with differentiated thyroid carcinoma (DTC). Results: Radio-active iodine (RAI) treatment was performed in 131 patients (91.6%), surgical approach and/or external radiotherapy in 68 patients (47.6%), and anti-resorptive bone-active drugs in 32 patients (22.4%; in 31 zoledronate and in one denosumab). At the start of treatment, 24 patients (75.0%) receiving anti-resorptive bone-active drugs had at least one clinical skeletal-related event (SRE) (p < 0.001). One or more clinical SREs (pathological fractures and/or malignant hypercalcemia and/or spinal cord compression) developed in 53 patients (37.1%). Development of SREs was significantly associated with metachronous BM (hazard ratio (HR) 2.04; p = 0.04), localization of BM to cervical spine (HR 3.89; p = 0.01), and lack of avid RAI uptake (HR 2.66; p = 0.02). Thirty-nine patients (27.3%) died in correlation with development of SREs (HR 6.97; p = 0.006) and localization of BM to the hip (HR 3.86; p = 0.02). Moreover, overall mortality was significantly decreased by RAI therapy (HR 0.10; p = 0.02), whereas no significant effects were induced by bone-active drugs (p = 0.36), external radiotherapy (p = 0.54), and surgery (p = 0.43) of BM. Conclusions: SREs are very frequent in BM from DTC and they impact patient survival. In the real life, the use of bone-active drugs is currently limited to zoledronate in patients with pre-existing SREs. In this clinical setting, RAI therapy, but not zoledronate, decreased mortality. © 2017, Springer Science+Business Media, LLC.
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience
| ▼ Clinical Oncology |
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience
Other filter: ([btitle,keywords] "Bone Metastases" OR ...
Gallicchio R, Mastrangelo PA, Nardelli A, Mainenti PP, Colasurdo AP, Landriscina M, Guglielmi G, Storto G
* Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why (141 views)
Tumori (ISSN: 0300-8916linking, 0300-8916print), 2019 May 16; N/D: 300891619851376-300891619851376.
Impact Factor: 1.304
View Export to BibTeX Export to EndNote
Orlandella FM, Mariniello RM, Iervolino PLC, Auletta L, De Stefano AE, Ugolini C, Greco A, Mirabelli P, Pane K, Franzese M, Denaro M, Basolo F, Salvatore G
* Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 alpha/beta pathways (205 views)
Mol Carcinog (ISSN: 0899-1987linking), 2019 Mar 4; 58(7): 1181-1193.
Impact Factor: 3.851
View Export to BibTeX Export to EndNote
Russo M, Malandrino P, Moleti M, Vermiglio F, Violi MA, Marturano I, Minaldi E, Vigneri R, Pellegriti G, Regalbuto C
* Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods (269 views)
J Endocrinol Invest (ISSN: 1720-8386, 0391-4097, 1720-8386electronic), 2017 May 20; 40(11): 1235-1241.
Impact Factor: 3.166
View Export to BibTeX Export to EndNote
Greco A, Albanese S, Auletta L, Mirabelli P, Zannetti A, D'Alterio C, Di Maro G, Orlandella FM, Salvatore G, Soricelli A, Salvatore M
* High-frequency ultrasound-guided injection for the generation of a novel orthotopic mouse model of human thyroid carcinoma (493 views)
Thyroid (ISSN: 1050-7256, 1050-7256linking), 2016 Feb 4; 26(4): 552-558.
Impact Factor: 5.515
View Export to BibTeX Export to EndNote
De Luca S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S
* Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma (332 views)
Ann Nucl Med (ISSN: 0914-7187, 1864-6433, 0914-7187linking), 2016 Jan 11; 30(3): 1-8.
Impact Factor: 1.396
View Export to BibTeX Export to EndNote
Albanese S, Auletta L, Zannetti A, Di Maro G, Mirabelli P, D'Alterio C, Salvatore G, Soricelli A, Salvatore M, Greco A
* High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma (371 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42: S416-S416.
Impact Factor: 5.537
View Export to BibTeX Export to EndNote
Formicola F, Riccardi A, Vigliar E, Biondi B, Accurso A, Del Vecchio W, Imbriaco M
* Multimetastatic medullary thyroid carcinoma to the breast: PET/CT--mammographic-US and MR findings (262 views)
Breast J (ISSN: 1075-122x), 2014 Nov; 20(6): 653-654.
Impact Factor: 1.411
View Export to BibTeX Export to EndNote
Gallicchio R, Giacomobono S, Nardelli A, Pellegrino T, Simeon V, Gattozzi D, Maddalena F, Mainenti PP, Storto G
* Palliative Treatment Of Bone Metastases With Samarium-153 Edtmp At Onset Of Pain (395 views)
J Bone Miner Metab (ISSN: 0914-8779), 2014 Jul; 32(4): 434-440.
Impact Factor: 2.46
View Export to BibTeX Export to EndNote
Fonti R, Mainolfi C, Anzivino A, Camera L, Faggiano A, Colao A, Salvatore M, Del Vecchio S
* 18F-FDG-PET/CT and 111In-Octreotide SPECT in Patients with Metastatic Medullary Thyroid Carcinoma (270 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
D'Antuono F, Nardelli A, Gallicchio R, Giacomobono S, Venetucci A, Pellegrino T, Leggiadro F, D'Errico N, Gattozzi D, Mainenti PP, Storto G
* Palliative Treatment of Bone Metastases with Sm-153 EDTMP at Pain Onset (287 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (430 views)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Impact Factor: 3.527
View Export to BibTeX Export to EndNote
Passaro C, Abagnale A, Libertini S, Volpe M, Botta G, Cella L, Pacelli R, Halldèn G, Gillespie D, Portella G
* Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells (444 views)
Endocr Relat Cancerendocrine Related Cancer (ISSN: 1351-0088), 2013 Sep 19; 20(5): 633-647.
Impact Factor: 4.907
View Export to BibTeX Export to EndNote
Storto G, Gallicchio R, Pellegrino T, Nardelli A, Capacchione D, Sirignano C, Pace L
* Impact of F-18-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP (346 views) (PDF 10 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897, 0969-8051linking), 2013 May; 40(4): 518-523.
Impact Factor: 2.408
View Export to BibTeX Export to EndNote
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (456 views)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
View Export to BibTeX Export to EndNote
D'Angelo D, Borbone E, Palmieri D, Uboldi S, Esposito F, Frapolli R, Pacelli R, D'Incalci M, Fusco A
* The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin (395 views)
European Journal Of Cancer (ISSN: 0959-8049), 2013 Mar; 49(5): 1142-1151.
Impact Factor: 4.819
View Export to BibTeX Export to EndNote
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (479 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Caleo O, Maurea S, Klain M, Salvatore B, Storto G, Mancini M, Pace L, Salvatore M
* Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose (287 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2009 Dec; 114(8): 1385-1385.
Impact Factor: 1.454
View Export to BibTeX Export to EndNote
Pace L, Nicolai E, Klain M, Salvatore M
* Diagnostic value of FDG PET/CT imaging (354 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009; 53(5): 503-512.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Storto G, Pellegrino T, Nardelli A, De Falco T, Castaldi E, Ortosecco G, Capasso E, Erra P, Speranza A, Klain M, Molino L, Di Nuzzo C, Pace L, Salvatore M
* Impact of PET-CT with F-18 Fluoride in Implementing Treatment of Painful Bone Metastases with Sm-153 EDTMP (288 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
View Export to BibTeX Export to EndNote
Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M
* Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation (367 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2008 Mar; 52(1): 2-8.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Caleo O, Maurea S, Klain M, Salvatore B, Storto G, Mancini M, Pace L, Salvatore M
* Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose (299 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2008 Mar; 113(2): 278-288.
Impact Factor: 0.955
View Export to BibTeX Export to EndNote
Storto G, Klain M, Paone G, Liuzzi R, Molino L, Marinelli A, Soricelli A, Pace L, Salvatore M
* Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases (390 views)
Bone (ISSN: 8756-3282), 2006 Jul; 39(1): 35-41.
Impact Factor: 3.829
View Export to BibTeX Export to EndNote
Iommelli F, Zannetti A, Pepe S, Sabbatino F, Laus G, Ghidelli L, Solla R, Scala S, Del Vecchio S, Salvatore M, Pacelli R
* Inhibition of NF-kappa B activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells (422 views)
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 2006 Apr; 47: N/D-N/D.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Pace L, Klain M, Albanese C, Salvatore B, Storto G, Soricelli A, Salvatore M
* Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment (396 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Feb; 33(2): 179-183.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Storto G, Paone G, Klain M, Salvatore B, Capacchione D, Soricelli A, Pace L, Salvatore M
* Hematological Toxicity in Patients with Painful Bone Metastases Treated with Sr-89 and Zoledronic Acid (210 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Impact Factor: 3.883
View Export to BibTeX Export to EndNote
Pace L, Klain M, Soricelli A, Albanese C, Salvatore B, Storto G, Salvatore M
* Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy (334 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: 179-183.
Impact Factor: 3.883
View Export to BibTeX Export to EndNote
Cozzolino R, Palladino P, Rossi F, Cali G, Benedetti E, Laccetti P
* Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis (524 views)
Carcinogenesis (ISSN: 0143-3334), 2005 Apr; 26(4): 733-739.
Impact Factor: 5.108
View Export to BibTeX Export to EndNote
Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, Mainenti PP, De Rosa G, Colao A, Contegiacomo A
* Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LAR (328 views)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2005 Apr; 28(4): 371-378.
Impact Factor: 1.496
View Export to BibTeX Export to EndNote
Storto G, Paone G, Ibello F, Klain M, Liuzzi R, Marinelli A, Soricelli A, Pace L, Salvatore M
* Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases (293 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
Impact Factor: 3.935
View Export to BibTeX Export to EndNote
Portella G, Pacelli R, Libertini S, Cella L, Vecchio G, Salvatore M, Fusco A
* ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells (467 views)
J Clin Endocrinol Metab Journal Of Clinical Endocrinology And Metabolism (ISSN: 0021-972x), 2003 Oct 1; 88(10): 5027-5032.
Impact Factor: 5.873
View Export to BibTeX Export to EndNote
Spalletti-cernia D, Sorrentino R, Di Gaetano S, Arciello A, Garbi C, Piccoli R, D'Alessio G, Vecchio G, Laccetti P, Santoro M
* Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis (384 views)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2003 Jun; 88(6): 2900-2907.
Impact Factor: 5.873
View Export to BibTeX Export to EndNote
Kim KM, Varrone A, Watabe H, Shidahara M, Fujita M, Innis RB, Iida H
* Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities (278 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2003 Apr; 44(4): 512-519.
Impact Factor: 4.899
View Export to BibTeX Export to EndNote
Colao A, Lastoria S, Ferone D, Varrella P, Marzullo P, Pivonello R, Cerbone G, Acampa W, Salvatore M, Lombardi G
The pituitary uptake of In-111-DTPA-D-Phe(1)-octreotide in the normal pituitary and in pituitary adenomas (387 views)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 1999 Mar; 22(3): 176-183.
Impact Factor: 0.957
View Export to BibTeX Export to EndNote
Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (373 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
View Export to BibTeX Export to EndNote
Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas (317 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1998 Jan; 83(1): 248-252.
Impact Factor: 5.641
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli, Salvatore M, Lassen NA
123I-iomazenil as a clinical tool for studying neuronal loss [4] (340 views)
J Am Geriatr Soc (ISSN: 0002-8614), 1997 Apr; 45(4): 534-536.
Impact Factor: 2.806
View Export to BibTeX Export to EndNote
Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M, Sacca L
Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine (336 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1996 Dec; 81(12): 4224-4228.
Impact Factor: 4.575
View Export to BibTeX Export to EndNote
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (450 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
Lastoria S, Maurea S, Vergara E, Acampa W, Varrella P, Klain M, Muto P, Bernardy JD, Salvatore M
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors (336 views)
Q J Nucl Med (ISSN: 1125-0135, 1124-3937), 1995 Dec; 39(4Suppl1): 145-149.
Impact Factor: 2.125
View Export to BibTeX Export to EndNote
Maurea S, Cuocolo A, Reynolds J, Keiser H, Neumann R, Salvatore M
Iodine-131 metaiodobenzylguanidine scintigraphy in the evaluation of paragangliomas. Comparison between benign and malignant tumors (252 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 1994; 87(5): 688-693.
Impact Factor: 0.967
View Export to BibTeX Export to EndNote
Maurea S, Maurelli L, Lastoria S, Cuocolo A, Brunetti A, Pace L, Caracò C, Klain M, Lupoli G, Salvatore M
Familial pheochromocytoma in Sipple's syndrome. A comparison between scintigraphy with 131I-meta-iodobenzylguanidine, computed tomography and echography (251 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 1992; 83(4): 486-490.
Impact Factor: 0.967
View Export to BibTeX Export to EndNote
Maurelli L, Cuocolo A, Lastoria S, Brunetti A, Maurea S, Lembo G, Klain M, Carac C, Salvatore M
131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters (442 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 1991; 82(6): 839-843.
Impact Factor: 0.967
View Export to BibTeX Export to EndNote
Marchetti P, Benzi L, Trischitta V, Brunetti A, Cecchetti P, Ciccarone AM, Pezzino V, Vigneri R, Navalesi R
Complementary use of gel permeation and reversed-phase liquid chromatography for the analysis of A14-[125I]insulin and its degradation products in isolated human monocytes (1719 views)
J Chromatogr B Biomed Sci Appl (ISSN: 0378-4347), 1986 Apr 25; 377(C): 339-344.
Impact Factor: 1.588
View Export to BibTeX Export to EndNote
* Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why (141 views)
Tumori (ISSN: 0300-8916linking, 0300-8916print), 2019 May 16; N/D: 300891619851376-300891619851376.
Impact Factor: 1.304
View Export to BibTeX Export to EndNote
Orlandella FM, Mariniello RM, Iervolino PLC, Auletta L, De Stefano AE, Ugolini C, Greco A, Mirabelli P, Pane K, Franzese M, Denaro M, Basolo F, Salvatore G
* Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 alpha/beta pathways (205 views)
Mol Carcinog (ISSN: 0899-1987linking), 2019 Mar 4; 58(7): 1181-1193.
Impact Factor: 3.851
View Export to BibTeX Export to EndNote
Russo M, Malandrino P, Moleti M, Vermiglio F, Violi MA, Marturano I, Minaldi E, Vigneri R, Pellegriti G, Regalbuto C
* Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods (269 views)
J Endocrinol Invest (ISSN: 1720-8386, 0391-4097, 1720-8386electronic), 2017 May 20; 40(11): 1235-1241.
Impact Factor: 3.166
View Export to BibTeX Export to EndNote
Greco A, Albanese S, Auletta L, Mirabelli P, Zannetti A, D'Alterio C, Di Maro G, Orlandella FM, Salvatore G, Soricelli A, Salvatore M
* High-frequency ultrasound-guided injection for the generation of a novel orthotopic mouse model of human thyroid carcinoma (493 views)
Thyroid (ISSN: 1050-7256, 1050-7256linking), 2016 Feb 4; 26(4): 552-558.
Impact Factor: 5.515
View Export to BibTeX Export to EndNote
De Luca S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S
* Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma (332 views)
Ann Nucl Med (ISSN: 0914-7187, 1864-6433, 0914-7187linking), 2016 Jan 11; 30(3): 1-8.
Impact Factor: 1.396
View Export to BibTeX Export to EndNote
Albanese S, Auletta L, Zannetti A, Di Maro G, Mirabelli P, D'Alterio C, Salvatore G, Soricelli A, Salvatore M, Greco A
* High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma (371 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42: S416-S416.
Impact Factor: 5.537
View Export to BibTeX Export to EndNote
Formicola F, Riccardi A, Vigliar E, Biondi B, Accurso A, Del Vecchio W, Imbriaco M
* Multimetastatic medullary thyroid carcinoma to the breast: PET/CT--mammographic-US and MR findings (262 views)
Breast J (ISSN: 1075-122x), 2014 Nov; 20(6): 653-654.
Impact Factor: 1.411
View Export to BibTeX Export to EndNote
Gallicchio R, Giacomobono S, Nardelli A, Pellegrino T, Simeon V, Gattozzi D, Maddalena F, Mainenti PP, Storto G
* Palliative Treatment Of Bone Metastases With Samarium-153 Edtmp At Onset Of Pain (395 views)
J Bone Miner Metab (ISSN: 0914-8779), 2014 Jul; 32(4): 434-440.
Impact Factor: 2.46
View Export to BibTeX Export to EndNote
Fonti R, Mainolfi C, Anzivino A, Camera L, Faggiano A, Colao A, Salvatore M, Del Vecchio S
* 18F-FDG-PET/CT and 111In-Octreotide SPECT in Patients with Metastatic Medullary Thyroid Carcinoma (270 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
D'Antuono F, Nardelli A, Gallicchio R, Giacomobono S, Venetucci A, Pellegrino T, Leggiadro F, D'Errico N, Gattozzi D, Mainenti PP, Storto G
* Palliative Treatment of Bone Metastases with Sm-153 EDTMP at Pain Onset (287 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (430 views)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Impact Factor: 3.527
View Export to BibTeX Export to EndNote
Passaro C, Abagnale A, Libertini S, Volpe M, Botta G, Cella L, Pacelli R, Halldèn G, Gillespie D, Portella G
* Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells (444 views)
Endocr Relat Cancerendocrine Related Cancer (ISSN: 1351-0088), 2013 Sep 19; 20(5): 633-647.
Impact Factor: 4.907
View Export to BibTeX Export to EndNote
Storto G, Gallicchio R, Pellegrino T, Nardelli A, Capacchione D, Sirignano C, Pace L
* Impact of F-18-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP (346 views) (PDF 10 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897, 0969-8051linking), 2013 May; 40(4): 518-523.
Impact Factor: 2.408
View Export to BibTeX Export to EndNote
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (456 views)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
View Export to BibTeX Export to EndNote
D'Angelo D, Borbone E, Palmieri D, Uboldi S, Esposito F, Frapolli R, Pacelli R, D'Incalci M, Fusco A
* The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin (395 views)
European Journal Of Cancer (ISSN: 0959-8049), 2013 Mar; 49(5): 1142-1151.
Impact Factor: 4.819
View Export to BibTeX Export to EndNote
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (479 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Caleo O, Maurea S, Klain M, Salvatore B, Storto G, Mancini M, Pace L, Salvatore M
* Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose (287 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2009 Dec; 114(8): 1385-1385.
Impact Factor: 1.454
View Export to BibTeX Export to EndNote
Pace L, Nicolai E, Klain M, Salvatore M
* Diagnostic value of FDG PET/CT imaging (354 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009; 53(5): 503-512.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Storto G, Pellegrino T, Nardelli A, De Falco T, Castaldi E, Ortosecco G, Capasso E, Erra P, Speranza A, Klain M, Molino L, Di Nuzzo C, Pace L, Salvatore M
* Impact of PET-CT with F-18 Fluoride in Implementing Treatment of Painful Bone Metastases with Sm-153 EDTMP (288 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
View Export to BibTeX Export to EndNote
Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M
* Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation (367 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2008 Mar; 52(1): 2-8.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Caleo O, Maurea S, Klain M, Salvatore B, Storto G, Mancini M, Pace L, Salvatore M
* Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose (299 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2008 Mar; 113(2): 278-288.
Impact Factor: 0.955
View Export to BibTeX Export to EndNote
Storto G, Klain M, Paone G, Liuzzi R, Molino L, Marinelli A, Soricelli A, Pace L, Salvatore M
* Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases (390 views)
Bone (ISSN: 8756-3282), 2006 Jul; 39(1): 35-41.
Impact Factor: 3.829
View Export to BibTeX Export to EndNote
Iommelli F, Zannetti A, Pepe S, Sabbatino F, Laus G, Ghidelli L, Solla R, Scala S, Del Vecchio S, Salvatore M, Pacelli R
* Inhibition of NF-kappa B activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells (422 views)
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 2006 Apr; 47: N/D-N/D.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Pace L, Klain M, Albanese C, Salvatore B, Storto G, Soricelli A, Salvatore M
* Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment (396 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Feb; 33(2): 179-183.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Storto G, Paone G, Klain M, Salvatore B, Capacchione D, Soricelli A, Pace L, Salvatore M
* Hematological Toxicity in Patients with Painful Bone Metastases Treated with Sr-89 and Zoledronic Acid (210 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Impact Factor: 3.883
View Export to BibTeX Export to EndNote
Pace L, Klain M, Soricelli A, Albanese C, Salvatore B, Storto G, Salvatore M
* Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy (334 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: 179-183.
Impact Factor: 3.883
View Export to BibTeX Export to EndNote
Cozzolino R, Palladino P, Rossi F, Cali G, Benedetti E, Laccetti P
* Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis (524 views)
Carcinogenesis (ISSN: 0143-3334), 2005 Apr; 26(4): 733-739.
Impact Factor: 5.108
View Export to BibTeX Export to EndNote
Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, Mainenti PP, De Rosa G, Colao A, Contegiacomo A
* Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LAR (328 views)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2005 Apr; 28(4): 371-378.
Impact Factor: 1.496
View Export to BibTeX Export to EndNote
Storto G, Paone G, Ibello F, Klain M, Liuzzi R, Marinelli A, Soricelli A, Pace L, Salvatore M
* Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases (293 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
Impact Factor: 3.935
View Export to BibTeX Export to EndNote
Portella G, Pacelli R, Libertini S, Cella L, Vecchio G, Salvatore M, Fusco A
* ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells (467 views)
J Clin Endocrinol Metab Journal Of Clinical Endocrinology And Metabolism (ISSN: 0021-972x), 2003 Oct 1; 88(10): 5027-5032.
Impact Factor: 5.873
View Export to BibTeX Export to EndNote
Spalletti-cernia D, Sorrentino R, Di Gaetano S, Arciello A, Garbi C, Piccoli R, D'Alessio G, Vecchio G, Laccetti P, Santoro M
* Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis (384 views)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2003 Jun; 88(6): 2900-2907.
Impact Factor: 5.873
View Export to BibTeX Export to EndNote
Kim KM, Varrone A, Watabe H, Shidahara M, Fujita M, Innis RB, Iida H
* Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities (278 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2003 Apr; 44(4): 512-519.
Impact Factor: 4.899
View Export to BibTeX Export to EndNote
Colao A, Lastoria S, Ferone D, Varrella P, Marzullo P, Pivonello R, Cerbone G, Acampa W, Salvatore M, Lombardi G
The pituitary uptake of In-111-DTPA-D-Phe(1)-octreotide in the normal pituitary and in pituitary adenomas (387 views)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 1999 Mar; 22(3): 176-183.
Impact Factor: 0.957
View Export to BibTeX Export to EndNote
Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (373 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
View Export to BibTeX Export to EndNote
Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas (317 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1998 Jan; 83(1): 248-252.
Impact Factor: 5.641
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli, Salvatore M, Lassen NA
123I-iomazenil as a clinical tool for studying neuronal loss [4] (340 views)
J Am Geriatr Soc (ISSN: 0002-8614), 1997 Apr; 45(4): 534-536.
Impact Factor: 2.806
View Export to BibTeX Export to EndNote
Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M, Sacca L
Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine (336 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1996 Dec; 81(12): 4224-4228.
Impact Factor: 4.575
View Export to BibTeX Export to EndNote
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (450 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
Lastoria S, Maurea S, Vergara E, Acampa W, Varrella P, Klain M, Muto P, Bernardy JD, Salvatore M
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors (336 views)
Q J Nucl Med (ISSN: 1125-0135, 1124-3937), 1995 Dec; 39(4Suppl1): 145-149.
Impact Factor: 2.125
View Export to BibTeX Export to EndNote
Maurea S, Cuocolo A, Reynolds J, Keiser H, Neumann R, Salvatore M
Iodine-131 metaiodobenzylguanidine scintigraphy in the evaluation of paragangliomas. Comparison between benign and malignant tumors (252 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 1994; 87(5): 688-693.
Impact Factor: 0.967
View Export to BibTeX Export to EndNote
Maurea S, Maurelli L, Lastoria S, Cuocolo A, Brunetti A, Pace L, Caracò C, Klain M, Lupoli G, Salvatore M
Familial pheochromocytoma in Sipple's syndrome. A comparison between scintigraphy with 131I-meta-iodobenzylguanidine, computed tomography and echography (251 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 1992; 83(4): 486-490.
Impact Factor: 0.967
View Export to BibTeX Export to EndNote
Maurelli L, Cuocolo A, Lastoria S, Brunetti A, Maurea S, Lembo G, Klain M, Carac C, Salvatore M
131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters (442 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 1991; 82(6): 839-843.
Impact Factor: 0.967
View Export to BibTeX Export to EndNote
Marchetti P, Benzi L, Trischitta V, Brunetti A, Cecchetti P, Ciccarone AM, Pezzino V, Vigneri R, Navalesi R
Complementary use of gel permeation and reversed-phase liquid chromatography for the analysis of A14-[125I]insulin and its degradation products in isolated human monocytes (1719 views)
J Chromatogr B Biomed Sci Appl (ISSN: 0378-4347), 1986 Apr 25; 377(C): 339-344.
Impact Factor: 1.588
View Export to BibTeX Export to EndNote
43 Records (35 excluding Abstracts).
Total impact factor: 138.04 (111.394 excluding Abstracts).
Total 5 year impact factor: 134.992 (107.527 excluding Abstracts).
Total impact factor: 138.04 (111.394 excluding Abstracts).
Total 5 year impact factor: 134.992 (107.527 excluding Abstracts).
407 views. Last view on Friday 03 February 2023, 15:28:12
ibb.cnr.it
